Concepedia

LaTrice G. Vaughn

LG

Statistics

Publications

4

Citations

91

H-Index

4

Active since

2008

Affiliations

Eli Lilly (United States)(Current)

Indiana Cancer Consortium

Indiana University – Purdue University Indianapolis

Texas Oncology

The University of Kansas Cancer Center

LaTrice G. Vaughn is an author at Eli Lilly (United States) specializing in chemotherapy, metastatic breast cancer, and metastatic disease treatment.

Publications per year

2008–2011

4

Publications

4

Phase II Trial of Gemcitabine/Carboplatin (plus Trastuzumab in HER2-Positive Disease) in Patients with Metastatic Breast Cancer

David Loesch, Lina Asmar, Kristi McIntyre et al. · Clinical Breast Cancer · 2008 · 41 citations

, , +16

A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen

Lida A. Mina, Ian E. Krop, Robin Zoň et al. · Investigational New Drugs · 2009 · 30 citations

, , +14

A Phase II Trial of Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer Who Have Received Prior Taxane Therapy

John Pippen, Anthony Elias, Marcus A. Neubauer et al. · Clinical Breast Cancer · 2010 · 10 citations

, , +16

A pilot trial of itraconazole pharmacokinetics in patients with metastatic breast cancer.

F. O. Ademuyiwa, Qian Zhao, SM Perkins et al. · Journal of Clinical Oncology · 2011 · 10 citations

, , +16

1–4 of 4